Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC

Phase 1

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

First Posted Date: 2005-11-09

Last Posted Date: 2008-04-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT00250978

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2005-09-20

Last Posted Date: 2007-01-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 246

Registration Number: NCT00200187

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Not Applicable

Active, not recruiting

Conditions: Colorectal Neoplasms
COlorectal Carcinoma
Colorectal Cancer
Colorectal Tumor

Interventions: Drug: Iodine-124 labeled humanized A33 (antibody)

First Posted Date: 2005-09-20

Last Posted Date: 2024-05-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT00199862

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial

Phase 3

Completed

Conditions: Cancer

Interventions: Procedure: Acupuncture and questionnaires
Procedure: placebo acupuncture

First Posted Date: 2005-09-20

Last Posted Date: 2011-02-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 101

Registration Number: NCT00200096

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: Raloxifene followed by combination therapy
Drug: Exemestane followed by combination therapy

First Posted Date: 2005-09-20

Last Posted Date: 2023-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT00200174

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

Phase 3

Completed

Conditions: Hepatectomy
Pancreaticoduodenectomy

Interventions: Procedure: Standard of care
Procedure: Normovolemic Hemodilution (ANH)

First Posted Date: 2005-09-20

Last Posted Date: 2015-03-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 372

Registration Number: NCT00200148

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Phase 2

Completed

Conditions: Glioblastoma
Gliomas

Interventions: Drug: Temozolomide

First Posted Date: 2005-09-20

Last Posted Date: 2018-03-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 127

Registration Number: NCT00200161

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Phase 2

Active, not recruiting

Conditions: Hepatic Metastases
Colon Cancer
Rectal Cancer

Interventions: Drug: Bevacizumab HAI plus systemic chemotherapy
Drug: HAI plus systemic chemotherapy

First Posted Date: 2005-09-20

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 73

Registration Number: NCT00200200

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Follow Up Only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Follow Up Only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: Tetrathiomolybdate

First Posted Date: 2005-09-19

Last Posted Date: 2024-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT00195091

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer
Erectile Dysfunction

Interventions: Drug: sildenafil citrate and questionaires
Drug: placebo tablets and questionaires

First Posted Date: 2005-09-02

Last Posted Date: 2017-10-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 290

Registration Number: NCT00142506

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy